← back to search

Kari Furu

Norwegian Institute of Public Health ·
Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Maternal Mental Health During Pregnancy and Postpartum, Pregnancy and Medication Impact, Pharmacological Effects and Toxicity Studies, and Prenatal Substance Exposure Effects.
h-index
51
citations
11,798
works
255
NIH funding
primary concept
email

Recent publications

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
JAMA Internal Medicine 2023cited by 144position: middledoi
Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders
JAMA Neurology 2023cited by 75position: middledoi
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
JAMA Neurology 2022cited by 255position: middledoi
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations
Annals of Neurology 2022cited by 68position: lastdoi
Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US
JAMA Psychiatry 2022cited by 66position: middledoi
Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020
European Child & Adolescent Psychiatry 2022cited by 27position: middledoi
Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population‐based cohort study
Pharmacoepidemiology and Drug Safety 2021cited by 5position: middledoi
Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia
Pharmacoepidemiology and Drug Safety 2020cited by 56position: middledoi
Antipsychotic drug use in pregnancy: A multinational study from ten countries
Schizophrenia Research 2020cited by 53position: middledoi
Antidiabetic medication use during pregnancy: an international utilization study
BMJ Open Diabetes Research & Care 2019cited by 58position: middledoi
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
The Lancet Psychiatry 2018cited by 305position: middledoi
β-Blocker Use in Pregnancy and the Risk for Congenital Malformations
Annals of Internal Medicine 2018cited by 94position: middledoi
International trends in clozapine use: a study in 17 countries
Acta Psychiatrica Scandinavica 2017cited by 297position: middledoi
International trends in antipsychotic use: A study in 16 countries, 2005–2014
European Neuropsychopharmacology 2017cited by 273position: middledoi
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations
JAMA Psychiatry 2017cited by 140position: middledoi
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study
Diabetologia 2017cited by 69position: middledoi
Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries
European Journal of Clinical Pharmacology 2016cited by 67position: middledoi
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design
BMJ 2015cited by 186position: firstdoi
Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
PLoS ONE 2015cited by 110position: middledoi
Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination
New England Journal of Medicine 2013cited by 298position: middledoi
The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review
Pharmacoepidemiology and Drug Safety 2013cited by 211position: middledoi
Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
Current Drug Safety 2013cited by 118position: middledoi
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
JAMA 2013cited by 101position: middledoi
CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety 2013cited by 71position: middledoi
Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination
Obstetrical & Gynecological Survey 2013cited by 16position: middledoi
ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
Molecular Cell 2012cited by 3,645position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Helga Zoëga · University of Iceland15 papers (2013–2023)Mika Gissler · University College London11 papers (2013–2023)Helle Kieler · Karolinska University Hospital10 papers (2013–2022) · 9 papers (2013–2022)Anders Engeland · Norwegian Institute of Public Health9 papers (2013–2022)Jacqueline M. Cohen · McGill University Health Centre8 papers (2019–2023)Mette Nørgaard · Aarhus University8 papers (2013–2022)Maarit K. Leinonen · Aarhus University8 papers (2019–2023)Johan Reutfors · Karolinska University Hospital7 papers (2017–2022)Carolyn E. Cesta · Karolinska Institutet7 papers (2019–2023)Sonia Hernández–Dı́az · Harvard University7 papers (2017–2023)Krista F. Huybrechts · Harvard University7 papers (2017–2023)Kristjana Einarsdóttir · The University of Western Australia6 papers (2017–2022)Brian T. Bateman · Palo Alto University6 papers (2017–2023)Randi Selmer · Norwegian Institute of Public Health5 papers (2015–2022)Laura Pazzagli · Karolinska Institutet4 papers (2019–2023) · 4 papers (2013–2021)Alys Havard · The University of Sydney3 papers (2019–2020)Marie L. De Bruin · Utrecht University3 papers (2013–2017)Jari Haukka · McMaster University3 papers (2013–2017)